LE GOFF, C., PEETERS, S., DELEERSNYDER, J., COLLARD, G., FERRANTE, N., NIX, C., & CAVALIER, E. (15 November 2019). VALIDATION OF A NEW MAGNETIC BEAD-BASED SAMPLE PREPARATION KITS FOR URINARY CORTISOL and comparison with a home method used routinely in the lab [Poster presentation]. RBSLM annual congres. |
LE GOFF, C., Nyssen, L., FERRANTE, N., PEETERS, S., & CAVALIER, E. (21 May 2019). Validation of the serum iohexol LC-MS/MS method using iohexol deuterated (D5) as internal standard [Poster presentation]. Euromedlab, Barcelone, Spain. |
STOJKOVIC, V., Delanaye, P., COLLARD, G., FERRANTE, N., Le Goff, C., Lutteri, L., & Cavalier, E. (2019). Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR. Clinica Chimica Acta, 499, 123-127. doi:10.1016/j.cca.2019.08.032 Peer Reviewed verified by ORBi |
CAVALIER, E., ROUSSELLE, O., FERRANTE, N., CARLISI, I., LE GOFF, C., & Souberbielle, J.-C. (October 2013). Technical and clinical evaluation of the VITROS Immunodiagnostic Products 25-OH Vitamin D Total Assay - comparison with marketed automated immunoassays and a liquid chromatography - tandem mass spectrometry method. Clinical Chemistry and Laboratory Medicine, 51 (10), 1983-1989. doi:10.1515/cclm-2013-0138 Peer Reviewed verified by ORBi |
CAVALIER, E., LE GOFF, C., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., DELANAYE, P., & Souberbielle, J.-C. (May 2013). Comparison of the total error obtained with six immuno-assays for 25-hydroxy vitamin D with the minimal, desirable and optimal total allowable errors calculated according to the biological variation. Biochimica Clinica, 37 (SS), 259. Peer reviewed |
CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498. Peer reviewed |
LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on phosphocalcic metabolism biomarkers in healthy adults subjects. Osteoporosis International, 24 (S1), 282. Peer Reviewed verified by ORBi |
LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on bone biomarkers in healthy dults subjects. Osteoporosis International, 24 (S1), 329. Peer Reviewed verified by ORBi |
LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in healthy subjects. Osteoporosis International, 24 (S1), 279. Peer Reviewed verified by ORBi |
CAVALIER, E., DELANAYE, P., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., & MORANNE, O. (17 July 2012). Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two Measurements [Poster presentation]. AACC 2012, Los Angeles, United States. |
CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States. |
CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL [Poster presentation]. AACC 2012, Los Angeles, United States. |
CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States. |
CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP) [Poster presentation]. AACC 2012, Los Angeles, United States. |
FORTUNATO, A., LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., ROUSSELLE, O., FERRANTE, N., & CAVALIER, E. (May 2012). Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA Centaur Total Vitamin D [Poster presentation]. The joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinoly, Florence, Italy. |
CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., Koivula, M.-K., & Risteli, J. (May 2012). Observed Ranges for the Healthy Paediatrics in the Serum IDS-ISYS CrossLaps® (SCTX-I) [Poster presentation]. European Calcified Tissue Society 39th Annual Congress, Stockholm, Sweden. |
CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., & DELANAYE, P. (March 2012). Difference between total and intact assays for N-terminal propeptide of type I procollagen in renal impaired patients. Osteoporosis International, 23 (Supplement 2), 339. Peer Reviewed verified by ORBi |
DELANAYE, P., CARLISI, I., ROUSSELLE, O., FERRANTE, N., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact » [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland. |